Biopharma, Payers Seek National Guidelines For Prescribing Potential COVID-19 Drugs
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.